AML Clinical Trials

237 clinical trials for AML across international registries, including 63 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies — RECRUITING · PHASE4
• Intermediate-dose HAD Regimen for CEBPA Double-mutated AML — RECRUITING · NA
• A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML — RECRUITING · PHASE1
• Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML — RECRUITING · NA
• Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1 — RECRUITING · PHASE3
• Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia — RECRUITING · NA
• A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — RECRUITING · PHASE3
• A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — RECRUITING · PHASE1
• DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML — RECRUITING · PHASE3
• CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML — RECRUITING · PHASE1
• A Study of CRD3874-SI in People With Leukemia — RECRUITING · PHASE1
• Familial Investigations of Childhood Cancer Predisposition — RECRUITING
• Haplo-Cord HSCT for AML/MDS — RECRUITING · NA
• Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution — RECRUITING
• Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML — RECRUITING · PHASE1
• Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML — RECRUITING · PHASE1
• Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS — RECRUITING · PHASE2
• A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease — RECRUITING · PHASE2
• Biomarkers in Bone Marrow Supernatant for Predicting AML Chemosensitivity — RECRUITING
• Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML — RECRUITING · PHASE2
• Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML — RECRUITING · PHASE1
• The Efficacy of Triple Regimen in Newly Diagnosed AML Patients With FLT3 Mutation — RECRUITING · PHASE1
• Cardioprotection in AML — RECRUITING · PHASE2
• Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML — RECRUITING · PHASE1
• VEN+IDAC vs IDAC in AML — RECRUITING · PHASE2
• MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases — RECRUITING · PHASE2
• Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia — RECRUITING · PHASE1
• UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy — RECRUITING · PHASE1
• VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial — RECRUITING · PHASE2
• MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies — RECRUITING · PHASE2
• WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment — RECRUITING
• CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF) — RECRUITING · PHASE1
• Revumenib in Combination With 7+3 + Midostaurin in AML — RECRUITING · PHASE1
• A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies — RECRUITING · PHASE2
• A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation — RECRUITING · PHASE2
• Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials — RECRUITING
• Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders — RECRUITING · PHASE2
• A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies — RECRUITING · PHASE1
• CC-486 and Venetoclax for Acute Myeloid Leukemia — RECRUITING · PHASE1
• A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors — RECRUITING · PHASE1
• Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML — RECRUITING · PHASE2
• The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia — RECRUITING · PHASE3
• A Long Term Follow-up Study of TScan TCR-T Products — RECRUITING
• Leptin: A Marker for AML Chemo-Sensitivity — RECRUITING
• Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL) — RECRUITING · PHASE1
• The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT — RECRUITING · PHASE1
• Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia — RECRUITING · NA
• Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation — RECRUITING · PHASE2
• Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia — RECRUITING · PHASE1
• Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE2

Refine this search